title: [Justice challenges of pharmaceutical industry global research].
abstract: International research projects sponsored by the pharmaceutical industry are a recent modality of biomedical research, which is driven by interests that are not only scientific, but also commercial. This combination of interests is one of the natural consequences of globalization, which has brought unquestionable benefits for the world, but has also created a wider gap between the wealthy and the poor. Given that globalization has been led by the the world's leading economies, the level of injustice in the world has increased, often to the favor of the already wealthy. Globalization has a well-established dynamics, whose main characteristic is domain over the following: technological innovation, the organization of the production of goods and services, human needs, and consumption. International biomedical research fits well in this dynamics, and the result is often a poor distribution of benefits, added to a loss of scientific integrity for the sake of commercial interests. This phenomenon raises many ethical questions and it demands a reflection from different bioethical points of view, particularly an economic ethics and a global justice.
authors.affiliation: Universidad Nacional Autónoma de México, Programa de Maestría y Doctorado en Bioética, Apdo. Postal 6, 76900, Corregidora Querétaro, México. ricardomsps@yahoo.com
authors.forename: Ricardo
authors.initials: R
authors.lastname: Páez Moreno
mesh_terms: D035843:Biomedical Research / Q000941:ethics*; D003132:Commerce / Q000941:ethics; D004345:Drug Industry / Q000941:ethics*; D006801:Humans; D038622:Internationality; D015337:Multicenter Studies as Topic; D012935:Social Justice